Unit Leader

We explore novel targets suitable for controlling signal transduction and the effect of regulatory molecules.
* Due to the reorganization starting as new centers in April 2018, this laboratory is now belong to the Center for Integrative Medical Sciences. As for the latest information, please see the following URL below.
> The webpage of Laboratory for Applied Regulatory Network Analysis, Center for Integrative Medical Sciences
Unit Leader
Erik Arner
1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, JAPAN
Based on omics technologies developed at DGT, in particular unique transcriptome technology such as CAGE, we develop systems for identifcation of target proteins suitable for regulatory molecules and exploration of the effect of regulatory molecules. Specifically, we aim to develop technology for 1) identification of the best path to control a target signal transduction pathway, 2) exploration of the transcriptional effect of regulatory molecules at the cellular level, and 3) analysis of targets and regulatory molecules at the single cell level.
CLST was reorganized into three centers according to the RIKEN 4th Medium-Term Plan from April 1, 2018. For the latest information of Molecular Network Control Genomics Unit, please visit the following websites.
> The webpage of Laboratory for Applied Regulatory Network Analysis, Center for Integrative Medical Sciences [http://www.ims.riken.jp/labo/70/index.html]
> If you continue to browse this site, click here.